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Alpha-fetoprotein (AFP) is an oncofetal antigen pro-
duced by hepatocellular carcinomas (HCC). Previous
studies demonstrated that tumor-derived AFP (tAFP) is
a glycoprotein that has an immunosuppressive role on
natural killer (NK), T, B, and dendritic (DC) cells which
may play a role in HCC pathogenesis. Defects in NK
cells have been attributed to tAFP-mediated immuno-
suppression of DC. However, a direct tAFP effect on
NK cells remains unexplored. Here we compared the
ability of cord blood-derived AFP (nAFP) to that of
tAFP to modulate human NK cell activity and longevity
in vitro. Short-term exposure to tAFP and, especially,
nAFP proteins induced a unique pro-inflammatory, IL-2
hyperresponsive phenotype in healthy donor NK cells as
measured by CD69 upregulation, IL-1b, IL-6 and TNF
secretion, and enhanced tumor cell killing. In contrast,
extended co-culture with tAFP, but not nAFP, inhibited
NK cell proliferation and viability. NK cell activation
was directly mediated by the AFP protein itself, while
their viability was affected by the low molecular mass
cargo that co-purified with tAFP. Overall, these data
show that nAFP and tAFP induce similar yet distinct
changes in NK cell function and viability, respectively.
Defining the impact of circulating AFP on NK cells may
be crucial to understand the NK cell functional deficits
described in HCC patients.
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